Hepatitis C Associated B-Cell Non-Hodgkin Lymphoma: Impact of Combination Direct-Acting Antivirals and Chemotherapy by Myagmarjav Budeebazar, Delgerbat Boldbaatar, Khishigjargal Batsukh, Erdenetsogt Dungubat, Dagvadorj Yagaanbuyant, Naranjargal Dashdorj, Davaadorj Duger

Get full text

Impact of Hepatitis D Coinfection on the Hepatitis Flare during Chemotherapy for B-Cell Non-Hodgkin Lymphoma by Myagmarjav Budeebazar, Anir Enkhbat, Delgerbat Boldbaatar, Khishigjargal Batsukh, Altankhuu Murdoj, Erdenetsogt Dungubat, Dagvadorj Yagaanbuyant, Naranjargal Dashdorj, Davaadorj Duger

Get full text

Anti-HCV, HBsAg Positive Incidences Among Patients Aged 40 Years and Over Diagnosed with B- Non-Hodgkin’s Lymphoma: A Comparison with General Population of Same Age by Myagmarjav Budeebazar, Delgerbat Boldbaatar, Anir Enkhbat, Myadagsuren Sukhbaatar, Khishigjargal Batsukh, Altankhuu Mordorj, Erdenetsogt Dungubat, Dagvadorj Yagaanbuyant, Naranjargal Dashdorj, Davaadorj Duger

Get full text

Peripheral B cells from patients with hepatitis C virus-associated lymphoma exhibit clonal expansion and an anergic-like transcriptional profile by Amanda N. Henning, Myagmarjav Budeebazar, Delgerbat Boldbaatar, Dahgwahdorj Yagaanbuyant, Davaadorj Duger, Khishigjargal Batsukh, Huizhi Zhou, Ryan Baumann, Robert D. Allison, Harvey J. Alter, Naranjargal Dashdorj, Valeria De Giorgi

Get full text